In vitro experiments confirmed that END and ENL can ameliorate the imbalance of iron-related genes such as FTH1 and ACO1 by inhibiting the IL-6-mediated JAK/STAT3-HAMP pathway, thereby regulating local intestinal iron homeostasis under inflammatory conditions, contributing to relieving anemia burden. The gene discussed is FTH1; the disease is anemia (phenotype).